Muhammad Zohaib Khan. “FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 31, no. 9, Sept. 2024, pp. 4104-28, https://doi.org/10.53555/vgped651.